These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 3257170

  • 1. Alteration of human lymphokine-activated killer cell activity by manipulation of protein kinase C and cytosolic Ca2+.
    McCrady CW, Li F, Grant AJ, Merchant RE, Carchman RA.
    Cancer Res; 1988 Feb 01; 48(3):635-40. PubMed ID: 3257170
    [Abstract] [Full Text] [Related]

  • 2. Induction of tumoricidal activity and alterations of growth by interleukin-2 and manipulation of protein kinase C and cytosolic calcium in childhood acute lymphocytic leukemia cells.
    Massey GV, McCrady CW, Dunn NL, Russell EC, Carchman RA.
    Leukemia; 1989 Aug 01; 3(8):602-10. PubMed ID: 2787455
    [Abstract] [Full Text] [Related]

  • 3. Costimulatory signals are required for optimal proliferation of human natural killer cells.
    Robertson MJ, Manley TJ, Donahue C, Levine H, Ritz J.
    J Immunol; 1993 Mar 01; 150(5):1705-14. PubMed ID: 7679691
    [Abstract] [Full Text] [Related]

  • 4. Phorbol dibutyrate and ionomycin improve murine effector cell cytotoxicity.
    Hamby LS, Freeman JW, McGrath PC.
    J Surg Res; 1993 Feb 01; 54(2):115-21. PubMed ID: 8479168
    [Abstract] [Full Text] [Related]

  • 5. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
    Mulé JJ, Krosnick JA, Rosenberg SA.
    J Immunol; 1989 Jan 15; 142(2):726-33. PubMed ID: 2783444
    [Abstract] [Full Text] [Related]

  • 6. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A, Bell GI, Director EP.
    J Immunol; 1988 Jul 15; 141(2):690-8. PubMed ID: 3133414
    [Abstract] [Full Text] [Related]

  • 7. Induction of competence and progression signals in human T lymphocytes by phorbol esters and calcium ionophores.
    Kumagai N, Benedict SH, Mills GB, Gelfand EW.
    J Cell Physiol; 1988 Nov 15; 137(2):329-36. PubMed ID: 3263971
    [Abstract] [Full Text] [Related]

  • 8. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
    Maghazachi AA, Vujanovic NL, Herberman RB, Hiserodt JC.
    J Immunol; 1988 Apr 15; 140(8):2846-52. PubMed ID: 3258622
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of phorbol ester/calcium ionophore and phytohemagglutinin-induced signaling in human T lymphocytes. Demonstration of interleukin 2-independent transferrin receptor gene expression.
    Kumagai N, Benedict SH, Mills GB, Gelfand EW.
    J Immunol; 1988 Jan 01; 140(1):37-43. PubMed ID: 3121740
    [Abstract] [Full Text] [Related]

  • 14. Identification and selection of human lymphokine activated killer cell effectors and novel recycling intermediates by unique light-scattering properties.
    Loudon WG, Abraham SR, Owen-Schaub LB, Hemingway LL, Hemstreet GP, DeBault LE.
    Cancer Res; 1988 Apr 15; 48(8):2184-92. PubMed ID: 3258186
    [Abstract] [Full Text] [Related]

  • 15. Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes.
    Davis L, Lipsky PE.
    J Immunol; 1986 May 15; 136(10):3588-96. PubMed ID: 3486215
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
    Itoh K, Tilden AB, Balch CM.
    J Immunol; 1986 May 15; 136(10):3910-5. PubMed ID: 3084648
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells.
    Itoh K, Tilden AB, Kumagai K, Balch CM.
    J Immunol; 1985 Feb 15; 134(2):802-7. PubMed ID: 3917475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.